ID NOW™ COVID-19 by Abbott

Manufacturer Abbott  |  Available in North America
5.0
/
5.0
  |  1 reviews
Molecular. In minutes. On the front line.


ID NOW™ COVID-19 by Abbott product image
ID NOW™ COVID-19
Request Pricing

Receive your quote directly from the manufacturer.




Average Rating: 5.0
1 Scientist has reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2020

  • Organization: Anaheim Clinical Trials



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Always saving the day!
Rating: 5.0

  • Application Area: Diagnostic

"We are able to perform point of care COVID19 test in less than 20 minutes helping with our logistics."

Review date: 09 Feb 2021 | ID NOW™ COVID-19

The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.

Timely results enable healthcare professionals to make appropriate and more efficient treatment and infection control decisions. EUA supports flexible near-patient testing environments.

Benefits:

  • Positive results may be detected in as little as 5 minutes 
  • Negative results in 13 minutes
  • Molecular technology targeting COVID-19 RdRp gene
  • Designed for near-patient testing in a variety of healthcare environments
  • Room temperature storage
  • Direct sample types include: Nasal, Throat, and Nasopharyngeal swabs
  • Facilitates effective patient management

Product Overview

ID NOW™ COVID-19 by Abbott product image

ID NOW™ COVID-19

Manufacturer Abbott  |  Available in North America

5.0 / 5.0 | 1 reviews